𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Neuroleptic malignant syndrome associated with the use of risperidone, an atypical antipsychotic agent

✍ Scribed by Heidi Lee; James Ryan; George Mullett; Brian A. Lawlor


Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
248 KB
Volume
9
Category
Article
ISSN
0885-6222

No coin nor oath required. For personal study only.

✦ Synopsis


Neuroleptic malignant syndrome (NMS) is a rare and sometimes fatal adverse reaction to neuroleptic drugs. Atypical antipsychotic agents, such as risperidone, are thought to be less likely to cause N M S because of their phamacologiical profile. This is a case report of NMS associated with risperidone treatment. KEY woms-Risperidone, neuroleptic malignant syndrome, NMS, atypical neuroleptic.


πŸ“œ SIMILAR VOLUMES


The use of risperidone, an atypical neur
✍ Heidi Lee; John M. Cooney; Brian A. Lawlor πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 253 KB

## Abstract A case of senile dementia of Lewy body type (SDLBT) who developed severe and incapacitating extrapyramidal side‐effects (EPSE) following treatment with typical neuroleptics, but responded to and tolerated the new atypical neuroleptic risperidone, is described. The potential benefits of